Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q2 FY25 results · Jul–Sep 2024
Medplus Health Services reported revenue from operations of ₹1,576.17 crore (up 11.9% from Q2 FY24) and net profit of ₹38.70 crore (up 166.1% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,576.17 | 1,408.59 | +11.9% | 1,488.83 | +5.9% |
| Other income | 11.60 | 10.37 | +11.9% | 8.71 | +33.1% |
| Total income | 1,587.77 | 1,418.95 | +11.9% | 1,497.54 | +6.0% |
| Profit before tax | 47.78 | 16.44 | +190.6% | 17.79 | +168.6% |
| Net profit for the period | 38.70 | 14.54 | +166.1% | 14.34 | +169.8% |
| Attributable to shareholders of the company | 38.74 | 14.56 | +166.0% | 14.36 | +169.7% |
| EPS, basic (₹) | 3.24 | 1.22 | +165.6% | 1.20 | +170.0% |
| Net margin (%) | 2.5 | 1.0 | 1.0 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 156.23 | 98.67 | +58.3% | 178.33 | −12.4% |
| Other income | 2.25 | 1.76 | +27.5% | 1.84 | +22.3% |
| Total income | 158.48 | 100.44 | +57.8% | 180.17 | −12.0% |
| Profit before tax | 9.64 | (0.04) | Turned profit | 11.61 | −17.0% |
| Net profit for the period | 7.75 | (0.04) | Turned profit | 9.26 | −16.3% |
| EPS, basic (₹) | 0.65 | 0.05 | 13x | 0.77 | −15.6% |
| Net margin (%) | 5.0 | -0.0 | 5.2 |
Consolidated
- Filed with BSE
- 13 Nov 2024, 11:48 IST
- Board meeting
- 12 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Nov 2024, 11:48 IST
- Board meeting
- 12 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE